Treatment of erectile dysfunction in patients with essential hypertension and ischemic heart disease. To evaluate the effect of impasa on activity of N0-dependent processes in cardiological patients with erectile dysfunction (ED).58 patients with IHD and angina of effort and 48 patients with hypertension participated in the study of efficacy of conventional treatment combined with impasa on the course of the basic disease, peripheral blood count of desquamated endotheliocytes, microcirculation and erectile function.IHD patients given impasa showed increased exercise tolerance, less number of anginal attacks, improved coronary microcirculation, improved metabolism of vascular endothelium. Manifestations of erectile dysfunction regressed. Hypotensive therapy also reduced the above manifestations in hypertensive patients.The addition of impasa to conventional cardiotropic and hypotensive therapy promotes ED regression.